Category: Life Sciences
Global Life Sciences
-
Viral Inactivation
... at a CAGR of 11.6% over the analysis period 2023-2030. Viral Inactivation Kits & Reagents, one of the segments analyzed in the report, is expected to record a 11.5% CAGR and reach US$777.3 Million by ... Read More
-
Urinalysis
... of 5% over the period 2023-2030. Urinalysis Consumables, one of the segments analyzed in the report, is expected to record 5.3% CAGR and reach US$4.1 Billion by the end of the analysis period. Growth in ... Read More
-
Counter Cyber Terrorism
... by 2030, growing at a CAGR of 2.9% over the analysis period 2023-2030. Firewall, one of the segments analyzed in the report, is expected to record a 3.2% CAGR and reach US$19.1 Billion by the ... Read More
-
C-Reactive Protein Testing
... by 2030, growing at a CAGR of 1.8% over the analysis period 2023-2030. C-Reactive Protein Testing for Cardiovascular Diseases, one of the segments analyzed in the report, is expected to record a 2.6% CAGR and ... Read More
-
Pneumonia Testing
... at a CAGR of 6.3% over the analysis period 2023-2030. Immunodiagnostics Method, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$339.9 Million by the end of ... Read More
-
Aortic Stent Grafts
... by 2030, growing at a CAGR of 4.9% over the analysis period 2023-2030. Abdominal Aortic Stent Grafts, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$2.9 ... Read More
-
De-Aromatic Solvents
... at a CAGR of 4.2% over the analysis period 2023-2030. Paints, Coatings & Inks Application, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$948.5 Million by ... Read More
-
Dental Digital X-ray
... by 2030, growing at a CAGR of 6.0% over the analysis period 2023-2030. Extraoral X-ray, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$1.2 Billion by ... Read More
-
Infant Clinical Nutrition
... by 2030, growing at a CAGR of 4.9% over the analysis period 2023-2030. Milk-Based Infant Clinical Nutrition, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$27.2 ... Read More
-
Insoluble Dietary Fibers
... by 2030, growing at a CAGR of 7.9% over the analysis period 2023-2030. Cereals & Grains-sourced Insoluble Dietary Fibers, one of the segments analyzed in the report, is expected to record a 8.5% CAGR and ... Read More
-
Curcumin
... of 8.7% over the analysis period 2023-2030. Conventional Curcumin, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$139.3 Million by the end of the analysis period. ... Read More
-
Dairy Enzymes
... at a CAGR of 6.8% over the analysis period 2023-2030. Chymosin, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$442.0 Million by the end of the ... Read More
-
Polymerase Chain Reaction
... by 2030, growing at a CAGR of 5.0% over the analysis period 2023-2030. PCR Instruments, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$3.4 Billion by ... Read More
-
Powered Surgical Instruments
... by 2030, growing at a CAGR of 3.7% over the analysis period 2023-2030. Electric Instruments, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$1.2 Billion by ... Read More
-
Prefilled Syringes
... at a CAGR of 8.6% over the analysis period 2023-2030. Conventional Prefilled Syringes, one of the segments analyzed in the report, is expected to record a 9.0% CAGR and reach US$8.8 Billion by the end ... Read More
-
Global Procalcitonin Test Kit Market Research Report 2024
... of 6.54% during the forecast period 2024-2030. North American market for Procalcitonin Test Kit is estimated to increase from $ 180.30 million in 2023 to reach $ 276.02 million by 2030, at a CAGR of ... Read More
-
ePharmacies
... of 14.8% over the analysis period 2023-2030. Over-The-Counter (OTC) Drugs, one of the segments analyzed in the report, is expected to record a 13.6% CAGR and reach US$123.3 Billion by the end of the analysis ... Read More
-
Angioplasty Balloons
... at a CAGR of 3.9% over the analysis period 2023-2030. Normal Balloons, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$2.1 Billion by the end of ... Read More
-
Antipsychotic Drugs
... at a CAGR of 6.7% over the analysis period 2023-2030. Second Generation Antipsychotic Drugs, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$15.7 Billion by the ... Read More
-
Dengue Testing
... at a CAGR of 4.9% over the analysis period 2023-2030. Hospitals End-Use, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$367.8 Million by the end of ... Read More
-
Intermittent Catheters
... at a CAGR of 4.1% over the analysis period 2023-2030. Urinary Incontinence Indication, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$1.6 Billion by the end ... Read More
-
Post-Traumatic Stress Disorder (PTSD) Therapeutics
... is expected to reach US$4.0 Billion by 2030, growing at a CAGR of 4.5% over the analysis period 2023-2030. Antidepressants, one of the segments analyzed in the report, is expected to record a 4.9% CAGR ... Read More
-
Prenatal Vitamin Supplements
... by 2030, growing at a CAGR of 6.5% over the analysis period 2023-2030. Gummy, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$174.5 Million by the ... Read More
-
Analytical Standards
... at a CAGR of 4.8% over the analysis period 2023-2030. Organic Analytical Standards, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$1.5 Billion by the end ... Read More
-
Dengue Vaccine
... at a CAGR of 15.8% over the analysis period 2023-2030. Government Institutions End-Use, one of the segments analyzed in the report, is expected to record a 14.2% CAGR and reach US$774.6 Million by the end ... Read More
Research Assistance
